Pen Needles Market worth $2,105 Million by 2019 - New Report by MarketsandMarkets

Share Article

The key factors that are expected to spur the growth of this market are the rising global diabetic population, favorable reimbursement scenario in North America and Europe.



Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-Strefa S.A. (Poland), Terumo Corporation (Japan), Artsana S.p.a (Italy), Owen Mumford Ltd (U.K.), Allison Medical, Inc. (U.S.), and Ultimed, Inc. (U.S.).

The “Pen Needles Market by by Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Therapy (Insulin, Growth Hormones, Glucagon-like peptide) & by Type (Standard and Safety) - Analysis & Global Forecast to 2019”analyzes and studies the major market drivers, threats, opportunities, and challenges.

Browse 101 market data tables and 51 figures spread through 185 pages and in-depth TOC on “Pen Needles Market by Type (Standard and Safety), by Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), by Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019”

Early buyers will receive 10% customization on this report.

The global pen needles market is segmented on the basis of type, needle length, therapy,and regions. This report studies the global pen needles marketfor the forecast period of 2014 to 2019.This market is expected to reach $2,105 million by 2019 from$1,283 millionin 2014, and is poised to grow at a CAGR of 10.4% during the forecast period.

Get Inquiry About Report @

On the basis of needle length,the pen needles market is segmented into 4 mm, 5 mm, 6 mm, 8 mm, 10 mm, and 12mm.Pen needles with 6mm length are expected to account for a major share of the pen needles market, by needle length in 2014. On the basis of therapy, the pen needles market is segmented into insulin, Glucagon-like peptide (GLP), and growth hormones. Insulin therapy account for major share of the pen needles market, by therapy in 2014. Based on type, the pen needles market is categorized into standard pen needles and safety pen needles.The standard pen needles segment is expected to account fora major share of the pen needles market, by type, in 2014.

The market is dominated by Europe, followed by North America, Asia, and Rest of the World (RoW). Asia is expected to reach leadership position in terms of the value by 2019.

Over the years, the demand for pen needles is likely to increase owing to favorable reimbursement environment in North America and Europe, strong government support in the Pacific region, advantages of insulin pens over syringes and vials, technological advancements in pen needle technologies, and growing diabetic population. However, poor reimbursement structure in developing countries, severe shortage of Endocrinologists in the U.S., threats involved in reuse of pen needles, rising incidents of needlestick injuries (NSIs), and alternative drug delivery methods are restraining the growth of this market. Rising use of safety pen needles is likely to create opportunities for the pen needles market. However, minimizing the usage of standard pen needles still remains a challenge for this market.

Some of the major players in the global pen needles market include Becton, Dickinson and Company (U.S.), Novo Nordisk Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-Strefa S.A. (Poland), Terumo Corporation (Japan), Artsana S.p.a (Italy), Owen Mumford Ltd (U.K.), Allison Medical, Inc. (U.S.), and Ultimed, Inc. (U.S.).

Browse Related Reports:
Human Insulin Market by Product Type [Human Insulin (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], by Brand (Lantus, Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to 2019
Infusion Pump Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018

About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Visit MarketsandMarkets Blog@
Connect with us on LinkedIn@

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Rohan
since: 04/2009
Follow >
Market Research Report
since: 12/2010
Like >
Follow us on
Visit website